莫里斯水上航行任务
超氧化物歧化酶
β淀粉样蛋白
化学
药理学
高架加迷宫
内分泌学
海马结构
氧化应激
医学
生物化学
肽
焦虑
精神科
作者
Muneeb Rehman,Angel Godad,Gaurav Doshi
标识
DOI:10.1080/0361073x.2023.2250227
摘要
The purpose of the study was to explore Edaravone and Noscapine in anAlCl3-induced Alzheimer's disease (AD) model.Morris Water Maze (MWM), Novel Object Recognition (NOR), andY-maze tests with TNF-α, IL-1, IL-6, amyloid-β, CAT, SOD and MDAlevels were performed, followed by brain histology.On the probe trial, the MWM demonstrated a decrease in escape latencyfollowed by an increase in the target quadrant. The NOR showeddiscrimination and recognition index scores and Y-maze, revealed arise in spontaneous alterations. TNF-α, IL-1, IL-6, amyloid-β, CATand MDA levels increased, while SOD levels dropped. The results werefound to be significant for combination full and half doses (***p <0.001, **p < 0.01). The treated group's histology ofbrain revealed mild neurodegeneration with hippocampal pyknoticnuclei.Thus, Edaravone and Noscapine can be used for thetreatment of AD. .Abbreviations: AlCl3: Aluminium chloride; AD: Alzheimer’s disease; Aβ: Amyloid plaques; APP: amyloid precursor protein; BACE 1: Serum beta-secretase 1; GSK3β: Glycogen synthase kinase 3 β; CDK 5: cyclin-dependent kinase-5; NFTs: neurofibrillary tangles; ROS: reactive oxygen species; JNK: c Jun N-terminal kinases; MWM: Morris Water Maze; NOR: Novel Object Recognition (NOR); TNF-α: Tumor necrosis factor -α; CAT: Catalase; SOD: Superoxide Dismutase; MDA: Malondialdehyde.
科研通智能强力驱动
Strongly Powered by AbleSci AI